Lightnews — Scholar-powered news

microDAO @microdao.bsky.social · 1h

The question is; how do we rebuild trust in medicine before resistance wins?

#AMR #GlobalHealth #MicroDAO #LetstalkAMR
iris.who.int/server/api/c...

1

microDAO @microdao.bsky.social · 1h

🦠 1 in 6 bacterial infections worldwide resisted antibiotics in 2023, This is 2025!

That’s not a headline, it’s a global warning.
Between 2018–2023, resistance rose in over 40% of key pathogen–antibiotic pairs.
AMR isn’t coming. It’s already here.👇

1

microDAO @microdao.bsky.social · 1d

From hospitals to households, smarter use = stronger medicine. 💊

🔗 Read more: [https://www.visualcapitalist.com/top-35-countries-by-antibiotic-use-see-u-s-ranks/]
#AMR #MicroDAO #LetstalkAMR

microDAO @microdao.bsky.social · 1d

Antibiotic use is rising fastest where access is easiest.
📈 Iran, South Africa, and Egypt lead global consumption; over 50 daily doses per 1,000 people, But misuse and over-prescription fuel antimicrobial resistance, a silent global crisis.👇

1 2

microDAO @microdao.bsky.social · 2d

AMR innovation needs a new kind of sustainability and DeSci might just be the key. 🌍

🔗 Read more: microdao.substack.com/p/learning-f...
#AMR #DeSci #MicroDAO #LetstalkAMR

Learning from the Pioneers: What Other BioDAOs Teach Us About Building Sustainable Science

In our previous post, we explored why AMR Innovation needs new funding models rather than the traditional models of funding, and how Web3 can help unlock new ways to sustain antimicrobial resistance…

microdao.substack.com

microDAO @microdao.bsky.social · 2d

How can decentralized science fuel real AMR breakthroughs? 💡
In our latest post, we dive into what MicroDAO can learn from BioDAOs like VitaDAO, MicrobiomeDAO & SpineDAO, from funding models to community building, to token allocation challenges.👇

Learning from the Pioneers: What Other BioDAOs Teach Us About Building Sustainable Science

In our previous post, we explored why AMR Innovation needs new funding models rather than the traditional models of funding, and how Web3 can help unlock new ways to sustain antimicrobial resistance…

microdao.substack.com

1

microDAO @microdao.bsky.social · 4d

Each represents a growing challenge in global health but where should MicroDAO focus first?
💭 Which of these do you think should be our top priority? The mic is yours 🎙️
Link: cdc.gov/mrsa/about

#AMR #GlobalHealth #MicroDAO #DeSci #InfectiousDiseases

microDAO @microdao.bsky.social · 4d

🥩 Drug-resistant Nontyphoidal Salmonella
🍗 Salmonella serotype Typhi
💉 Drug-resistant Shigella
⚕️ Methicillin-resistant Staphylococcus aureus (MRSA)
🫁 Drug-resistant Streptococcus pneumoniae
🧫 Drug-resistant Tuberculosis (TB)

1

microDAO @microdao.bsky.social · 4d

Let’s wrap up the week with a closer look at 11 pathogens the CDC classifies as Serious AMR Threats:

🦠 Drug-resistant Campylobacter
🧫 Drug-resistant Candida
💊 ESBL-producing Enterobacteriaceae
🧪 Vancomycin-resistant Enterococci (VRE)
🧬 Multidrug-resistant Pseudomonas aeruginosa

1

Reposted by microDAO

Varun Kothamachu @varunkothamachu.bsky.social · 11d

With a new enzyme for cell wall synthesis and an alternative cell division mechanism, mrsa has become highly resistant to antimicrobials

targetting these mechanisms can unlock new antimicrobials to tackle mrsa causes infections

sheffield.ac.uk/news/mrsas-d...

#letstalkaboutAMR

1 2

microDAO @microdao.bsky.social · 5d

A resistant threat anywhere can easily become a threat at home, Global capacity is needed to slow development and prevent spread of antibiotic disease.
You have to get involved, and the time is now🚦 !
Source: cdc.gov/mrsa/about

#letstalkaboutAMR

Methicillin-resistant Staphylococcus aureus (MRSA) Basics

Protect yourself and your family from potentially serious MRSA infections.

cdc.gov

microDAO @microdao.bsky.social · 5d

Antibiotic Resistance spreads easily across the globe 🌏, Resistant bacteria and fungi can spread across continent through people, animal and goods.
One billion people cross through international borders each year.👇

1 1

microDAO @microdao.bsky.social · 7d

N. gonorrhoeae: 75% fluoroquinolone resistance globally
Link: iris.who.int/server/api/c...

#AMR #MicroDAO

microDAO @microdao.bsky.social · 7d

The world’s antibiotics are losing power.

New data shows alarming AMR trends:
E. coli & K. pneumoniae: > 70% resistance in Africa
Acinetobacter spp.: 54.3% global carbapenem resistance
MRSA: 27% global > 50% in E. Mediterranean {👇}

1

microDAO @microdao.bsky.social · 8d

Each of these poses a critical global risk — resistant, difficult to treat, and spreading fast. 🌍

Which of these do you think represents the most serious global threat today?
#AMR #DeSci #MicroDAO #GlobalHealth #AntimicrobialResistance

microDAO @microdao.bsky.social · 8d

Here are the most urgent AMR threats right now:
🔹 Carbapenem-resistant Acinetobacter
🔹 Candida auris (C. auris)
🔹 Clostridioides difficile (C. difficile)
🔹 Carbapenem-resistant Enterobacteriaceae (CRE)
🔹 Drug-resistant Neisseria gonorrhoeae (N. gonorrhoeae)

1

microDAO @microdao.bsky.social · 8d

🦠 Understanding AMR Threats: What’s the Most Urgent?
According to the CDC’s 2019 AMR Threat Report, 18 major pathogens are classified into three categories: Urgent, Serious, and Concerning threats.{Athread}👇

1 1

microDAO @microdao.bsky.social · 10d

spreading through food, animals, and even the environment. 🌍

Together, we can change this narrative.
Join us and #letstalkaboutAMR 💜🧠

Read more 👉 www.cdc.gov/mrsa/about

Methicillin-resistant Staphylococcus aureus (MRSA) Basics

Protect yourself and your family from potentially serious MRSA infections.

www.cdc.gov

microDAO @microdao.bsky.social · 10d

🧫 WHO IS AT RISK OF A.M.R?

The answer is Everyone.
Antimicrobial resistance doesn’t discriminate, it can affect anyone, at any stage of life.

Those receiving healthcare or living with weakened immune systems face higher risks but AMR also moves beyond hospitals;

1

microDAO @microdao.bsky.social · 11d

and respond across environments, not just in clinical settings.
Link: www.cdc.gov/mrsa/about

Join us in the fight. 💜
#AMR #MicroDAO #OneHealth #DeSci

Methicillin-resistant Staphylococcus aureus (MRSA) Basics

Protect yourself and your family from potentially serious MRSA infections.

www.cdc.gov

microDAO @microdao.bsky.social · 11d

MRSA contributed to >100,000 AMR-attributable deaths in 2019, This is why AMR is about more than hospitals, it’s about tracking resistance everywhere it can emerge.

🔍 At MicroDAO, we’re focused on building surveillance & research tools so we can measure

Methicillin-resistant Staphylococcus aureus (MRSA) Basics

Protect yourself and your family from potentially serious MRSA infections.

www.cdc.gov

1

microDAO @microdao.bsky.social · 11d

🧬 Hello Micronauts! Did You Know?

Staphylococcus aureus (often just called “staph”) lives harmlessly in the nose or on the skin of 30% of people, but when it becomes methicillin-resistant (MRSA), it can resist multiple antibiotics making infections far harder to treat. #Athread

2 1 1

microDAO @microdao.bsky.social · 13d

Antimicrobial resistance (AMR) doesn’t just happen in hospitals — it’s in our food, soil, and water. 🌍🧫
At MicroDAO, we’re working to build a system where data, collaboration, and decentralization help us track resistance everywhere it matters.

1

microDAO @microdao.bsky.social · 14d

Happy New Week, Micronauts! 🌍💜
I hope we’re all starting the week strong.
This is a kind reminder to those who haven’t yet read our previous Substack post.
Your feedback and engagement are invaluable as we continue shaping the MicroDAO vision together.
🔗

Why AMR Innovation Needs New Funding Models, and How Web3 Can Help

In our earlier posts, we introduced MicroDAO’s vision: to build a new, decentralised infrastructure for tackling antimicrobial resistance (AMR), one of the most urgent and complex global health…

microdao.substack.com

microDAO @microdao.bsky.social · 17d

💡 AMR is one of the most urgent health threats today; broken funding systems slow innovation.

MicroDAO is rethinking the model:
✅ Decentralised fundraising
✅ Transparent incentives
✅ Global participation

Science needs new infrastructure. 🌍🧠
🔗 [https://shorturl.at/n3L29]

Why AMR Innovation Needs New Funding Models, and How Web3 Can Help

In our earlier posts, we introduced MicroDAO’s vision: to build a new, decentralised infrastructure for tackling antimicrobial resistance (AMR), one of the most urgent and complex global health…

microdao.substack.com

1